Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids JACC Focus Seminar

被引：37
|
作者：
Weinberg, Richard L. [1 ]
Brook, Robert D. [2 ]
Rubenfire, Melvyn [1 ]
Eagle, Kim A. [1 ]
机构：
[1] Univ Michigan, Dept Internal Med, Michigan Med, Div Cardiovasc Med,Frankel Cardiovasc Ctr, Ann Arbor, MI 48109 USA
[2] Wayne State Univ, Div Cardiol, Detroit, MI USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 05期
关键词：
docosahexaenoic acid; eicosapentaenoic acid; fish oil; omega-3 fatty acids; N-3; FATTY-ACIDS; FISH-OIL SUPPLEMENTS; RANDOMIZED CONTROLLED-TRIAL; HIGH TRIGLYCERIDE LEVELS; CORONARY-HEART-DISEASE; ESTER AMR101 THERAPY; EICOSAPENTAENOIC ACID; ICOSAPENT ETHYL; PRESCRIPTION OMEGA-3-FATTY-ACIDS; HYPERCHOLESTEROLEMIC PATIENTS;
D O I：
10.1016/j.jacc.2020.11.060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Omega-3 polyunsaturated fatty acids (PUFAs) are a key component of a heart-healthy diet. For patients without clinical atherosclerotic cardiovascular disease, 2 or more servings of fatty fish per week is recommended to obtain adequate intake of omega-3 PUFAs. If this not possible, dietary supplementation with an appropriate fish oil may be reasonable. Supplementation with omega-3 PUFA capsules serves 2 distinct but overlapping roles: treatment of hypertriglyceridemia and prevention of cardiovascular events. Marine-derived omega-3 PUFAs reduce triglycerides and have pleiotropic effects including decreasing inflammation, improving plaque composition and stability, and altering cellular membranes. Clinical trial data have shown inconsistent results with omega-3 PUFAs improving cardiovascular outcomes. In this paper, the authors provide an overview of PUFAs and a summary of key clinical trial data. Recent trial data suggest the use of prescription eicosapentaenoic acid ethyl ester for atherosclerotic cardiovascular disease event reduction in selected populations. (C) 2021 by the American College of Cardiology Foundation.
引用
收藏
页码：593 / 608
页数：16
相关论文
共 50 条
  • [1] Impact of Dietary Fats on Cardiovascular Disease with a Specific Focus on Omega-3 Fatty Acids
    Maggioni, Aldo Pietro
    Poli, Giuseppe
    Mannucci, Pier Mannuccio
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (22)
  • [2] Omega-3 fatty acids in the gravid pig uterus as affected by maternal supplementation with omega-3 fatty acids
    Brazle, A. E.
    Johnson, B. J.
    Webel, S. K.
    Rathbun, T. J.
    Davis, D. L.
    [J]. JOURNAL OF ANIMAL SCIENCE, 2009, 87 (03) : 994 - 1002
  • [3] TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS
    Handelsman, Yehuda
    Shapiro, Michael D.
    [J]. ENDOCRINE PRACTICE, 2017, 23 (01) : 100 - 112
  • [4] Omega-3 fatty acids and cardiovascular risk
    Nestel, PJ
    [J]. OMEGA-3 LIPOPROTEINS AND ATHEROSCLEROSIS, 1996, : 37 - 39
  • [5] Omega-3 fatty acids and cardiovascular disease
    Leaf, A
    Kang, JX
    [J]. NUTRITION AND FITNESS: DIET, GENES, PHYSICAL ACTIVITY AND HEALTH, 2001, 89 : 161 - 172
  • [6] Cardiovascular benefits of omega-3 fatty acids
    von Schacky, Clemens
    Harris, William S.
    [J]. CARDIOVASCULAR RESEARCH, 2007, 73 (02) : 310 - 315
  • [7] Omega-3 fatty acids and cardiovascular disease
    von Schacky, Clemens
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2007, 10 (02): : 129 - 135
  • [8] Omega-3 fatty acids and cardiovascular disease
    von Schacky, C
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2004, 7 (02): : 131 - 136
  • [9] Omega-3 fatty acids and cardiovascular prevention
    Paillard, F.
    [J]. SCIENCES DES ALIMENTS, 2010, 29 (3-4) : 123 - 127
  • [10] Omega-3 fatty acids and cardiovascular disease
    Jain, A. P.
    Aggarwal, K. K.
    Zhang, P. -Y.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (03) : 441 - 445
12345